Screening platform for development of antibody-drug conjugates against novel targets at the National Research Council of Canada

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1158/1538-7445.AM2017-3669
AuthorSearch for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 2
Affiliation
  1. National Research Council of Canada. Human Health Therapeutics
  2. National Research Council of Canada. Information and Communication Technologies
FormatText, Abstract
ConferenceAmerican Association for Cancer Research Annual Meeting 2017, April 1-5, 2017, Washington, DC, USA
Abstract
Publication date
PublisherAmerican Association for Cancer Research
In
Series
LanguageEnglish
Peer reviewedYes
NPARC number23002152
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifierc9fb2b50-9503-4ab7-8db7-3dfd20708eb6
Record created2017-08-25
Record modified2020-03-02
Date modified: